Market Overview

BlackBerry Ltd, AcelRx & Benzinga's Top PreMarket Losers

Related FINL
Barron's Picks And Pans: Alphabet, IAC, Spotify, Under Armour And More
The Week Ahead: Switch's Lockup Expires, Spotify Debuts, And More
JD Sports absorbs Finish Line (Seeking Alpha)
Related ACRX
Analyst: AcelRx Will Address FDA Concerns, Secure Approval This Year
Benzinga's Daily Biotech Pulse: Galmed Rips Higher On Positive NASH Data, Enzo Biochem Falls On Earnings, Pfenex Licenses Osteoporosis Candidate
AcelRx Sparks Investor Interest As It Gears Up For Another Shot With Dsuvia (Seeking Alpha)

AcelRx Pharmaceuticals (NASDAQ: ACRX) shares slipped 10.71% to $6.00 in pre-market trading after the company offered a regulatory update for Zalviso.

Finish Line (NASDAQ: FINL) fell 8.19% to $27.00 in pre-market trading after the company reported downbeat second-quarter results.

BlackBerry Ltd (NASDAQ: BBRY) shares dropped 2.55% to $9.55 in pre-market trading. The company reported a narrower-than-expected second-quarter loss. However, the company's revenue missed analysts' estimates.

Philip Morris International (NYSE: PM) dropped 0.60% to $83.20 in pre-market trading. Analysts at Bank of America downgraded Philip Morris International from Buy to Neutral and lowered the target price to $87.

Posted-In: #PreMarket LosersNews Movers & Shakers Pre-Market Outlook Markets


Related Articles (ACRX + BB)

View Comments and Join the Discussion!